Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
35.3M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$76.6M
-
Number of buys
-
57
-
Number of sells
-
-34
-
Price
-
$36.24
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q3 2016
110 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q3 2016.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.3M shares
of 49.8M outstanding shares and own 70.91% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (9.41M shares), BAUPOST GROUP LLC/MA (7.35M shares), FMR LLC (4.03M shares), VANGUARD GROUP INC (2.68M shares), BlackRock Fund Advisors (1.83M shares), Cormorant Asset Management, LLC (1.12M shares), FIRST MANHATTAN CO (1.04M shares), BlackRock Institutional Trust Company, N.A. (880K shares), NORGES BANK (867K shares), and STATE STREET CORP (719K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.